Predictive Modeling of Hypoglycemia Risk with Basal Insulin Use in Type 2 Diabetes: Use of Machine Learning in the LIGHTNING Study

por Bosnyak, Zsolt, Zhou, Fang Liz, Jimenez, Javier, Berria, Rachele
Publicado 2019

Hypoglycaemia risk with insulin glargine 300 U/mL compared with glargine 100 U/mL across different baseline fasting C‐peptide levels in insulin‐naïve people with type 2 diabetes: A...

por Bolli, Geremia B., Landgraf, Wolfgang, Bosnyak, Zsolt, Melas‐Melt, Lydie, Home, Philip D.
Publicado 2020

Maternal Glycemia and Risk of Large-for-Gestational-Age Babies in a Population-Based Screening

por Kerényi, Zsuzsa, Tamás, Gyula, Kivimäki, Mika, Péterfalvi, Andrea, Madarász, Eszter, Bosnyák, Zsolt, Tabák, Adam G.
Publicado 2009

InRange: Comparison of the Second-Generation Basal Insulin Analogues Glargine 300 U/mL and Degludec 100 U/mL in Persons with Type 1 Diabetes Using Continuous Glucose Monitoring—Stu...

por Battelino, Tadej, Bosnyak, Zsolt, Danne, Thomas, Mukherjee, Bhaswati, Edelman, Steve, Pilorget, Valerie, Choudhary, Pratik, Renard, Eric, Bergenstal, Richard
Publicado 2020

Glycaemic control and hypoglycaemia risk with insulin glargine 300 U/mL and insulin degludec 100 U/mL in older participants in the BRIGHT trial

por Bolli, Geremia B., Cheng, Alice, Charbonnel, Bernard, Aroda, Vanita R., Westerbacka, Jukka, Bosnyak, Zsolt, Boëlle‐Le Corfec, Emmanuelle, Rosenstock, Julio
Publicado 2021

Clinical outcomes in real‐world patients with type 2 diabetes switching from first‐ to second‐generation basal insulin analogues: Comparative effectiveness of insulin glargine 300...

por Sullivan, Sean D., Bailey, Timothy S., Roussel, Ronan, Zhou, Fang Liz, Bosnyak, Zsolt, Preblick, Ronald, Westerbacka, Jukka, Gupta, Rishab A., Blonde, Lawrence
Publicado 2018

Rates of Hypoglycemia Predicted in Patients with Type 2 Diabetes on Insulin Glargine 300 U/ml Versus First- and Second-Generation Basal Insulin Analogs: The Real-World LIGHTNING St...

por Pettus, Jeremy, Roussel, Ronan, Liz Zhou, Fang, Bosnyak, Zsolt, Westerbacka, Jukka, Berria, Rachele, Jimenez, Javier, Eliasson, Björn, Hramiak, Irene, Bailey, Timothy, Meneghini, Luigi
Publicado 2019

Comparable glycaemic control and hypoglycaemia in adults with type 2 diabetes after initiating insulin glargine 300 units/mL or insulin degludec: The DELIVER Naïve D real‐world stu...

por Sullivan, Sean D., Nicholls, Charlie J., Gupta, Rishab A., Menon, Arjun A., Wu, Jasmanda, Westerbacka, Jukka, Bosnyak, Zsolt, Frias, Juan P., Bailey, Timothy S.
Publicado 2019

Similar glycaemic control and less hypoglycaemia during active titration after insulin initiation with glargine 300 units/mL and degludec 100 units/mL: A subanalysis of the BRIGHT...

por Cheng, Alice, Harris, Stewart, Giorgino, Francesco, Seufert, Jochen, Ritzel, Robert, Khunti, Kamlesh, Lauand, Felipe, Melas‐Melt, Lydie, Westerbacka, Jukka, Bosnyak, Zsolt, Rosenstock, Julio
Publicado 2019

Differential glycaemic control with basal insulin glargine 300 U/mL versus degludec 100 U/mL according to kidney function in type 2 diabetes: A subanalysis from the BRIGHT trial

por Haluzík, Martin, Cheng, Alice, Müller‐Wieland, Dirk, Westerbacka, Jukka, Bosnyak, Zsolt, Lauand, Felipe, Melas‐Melt, Lydie, Karalliedde, Janaka, Rosenstock, Julio, Bolli, Geremia B.
Publicado 2020

The SAGE study: Global observational analysis of glycaemic control, hypoglycaemia and diabetes management in T1DM

por Renard, Eric, Ikegami, Hiroshi, Daher Vianna, André Gustavo, Pozzilli, Paolo, Brette, Sandrine, Bosnyak, Zsolt, Lauand, Felipe, Peters, Anne, Pilorget, Valerie, Jurišić‐Eržen, Dubravka, Kesavadev, Jothydev, Seufert, Jochen, Wilmot, Emma G.
Publicado 2021